SEARCH

SEARCH BY CITATION

References

  • Angelopoulou N, Matziari C, Tsimaras V, Sakadamis A, Souftas V, Mandroukas K. (2000) Bone mineral density in adults with Down’s syndrome. Calcif Tissue Int66:176180.
  • Baroncelli GI, Bertelloni S, Sodini F, Saggese G. (2005) Osteoporosis in children and adolescents: etiology and management. Paediatr Drugs7:295323.
  • Beerhorst K, Huvers FC, Renier WO. (2005) Severe early onset osteopenia and osteoporosis caused by antiepileptic drugs. J Med63:222226.
  • Budden SS, Gunness ME. (2003) Possible mechanisms of osteopenia in Rett syndrome: bone histomorphometric studies. J Child Neurol18:698702.
  • Center J, Beange H, McEldfuff A. (1998) People with mental retardation have an increased prevalence of osteoporosis: a population study. Am J Ment Retard103:1928.
  • Chung S, Ahn C. (1994) Effects of anti-epileptic drug therapy on bone mineral density in ambulatory epileptic children. Brain & Dev16:382385.
  • Colmenares A, Pinto G, Taupin P, Giuseppe A, Odent T, Trivin C, Laborde K, Souberbielle JC, Polak M. (2011) Effects on growth and metabolism of growth hormone treatment for 3 years in 36 children with Prader-Willi syndrome. Horm Res Paediatr75:123130.
  • Coppola G, Verrotti A, Mainolfi C, Auricchio G, Fortunato D, Operto FF, Pascotto A. (2007) Bone mineral density in Angelman syndrome. Pediatr Neurol37:411416.
  • Coppola G, Fortunato D, Auricchio G, Mainolfi C, Operto FF, Signoriello G, Pascotto A, Salvatore M. (2009) Bone mineral density in children, adolescents, and young adults with epilepsy. Epilepsia50:21402146.
  • Ecevit C, Aydogan A, Kavakli T, Altinoz S. (2004) Effect of carbamazepine and valproate on bone mineral density. Pediatr Neurol31:279282.
  • Erbayat Altay E, Serdaroglu A, Tumer L, Gucuyener K, Hasanoglu A. (2000) Evaluation of bone mineral metabolism in children receiving carbamazepine and valproic acid. J Pediatr Endocrinol Metab13:933999.
  • Farhat G, Yamout B, Mikati MA, Demirjian S, Sawaya R, El-Hajj Fuleihan G. (2002) Effect of antiepileptic drugs on bone density in ambulatory patients. Neurology58:13481353.
  • González-Agüero A, Vicente-Rodríguez G, Moreno LA, Casajús JA. (2011) Bone mass in male and female children and adolescents with Down syndrome. Osteoporos Int22:21512157.
  • Guo CY, Ronen GM, Atkinson SA. (2001) Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy. Epilepsia42:11411147.
  • Haas RH, Dixon SD, Sartoris D, Hennessy MJ. (1997) Osteopenia in Rett syndrome. J Pediatr13:771774.
  • Henderson RC, Lin PP, Greene WB. (1995) Bone-mineral density in children and adolescents who have spastic cerebral palsy. Bone Joint Surg Am11:16711681.
  • Henderson RC, Lark RK, Gurka MJ, Worley G, Fung EB, Conaway M, Stallings VA, Stevenson RD. (2002) Bone density and metabolism in children and adolescnets with moderate to severe cerebral palsy. Pediatrics110(1 Pt 1):e5.
  • Houlihan CM, Stevenson RD. (2009) Bone density in cerebral palsy. Phys Med Rehabil Clin N Am20:493508.
  • Hunter J, Maxwell JD, Stewart DA, Parsons V, Williams R. (1971) Altered calcium metabolism in epileptic children on anticonvulsants. Br Med J4:202204.
  • Kafali G, Erselcan T, Tanzer F. (1999) Effect of antiepileptic drugs on bone mineral density in children between ages 6 and 12 years. Clin Pediatr38:9398.
  • King W, Levine R, Schmidt R, Oestreich A, Heubi JE. (2003) Prevalence of reduced bone mass in children and adults with spastic quadriplegia. Dev Med Child Neurol45:1216.
  • Lee JJ, Lyne ED, Kleerekoper M, Logan MS, Belfi RA. (1989) Disorders of bone metabolism in severely handicapped children and young adults. Clin Orthop Relat Res245:297302.
  • Lewiecki EM, Gordon CM, Baim S, Binkley N, Bilezikian JP, Kendler DL, Hans DB, Silverman S, Bishop NJ, Leonard MB, Bianchi ML, Kalkwarf HJ, Langman CB, Plotkin H, Rauch F, Zemel BS. (2008) Special report on the 2007 adult and pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporos Int19:13691378.
  • McCloskey EV, Johansson H, Oden A, Kanis A. (2009) From relative to absolute fracture risk calculation: the FRAX algorithm. Curr Osteoporos Rep7:7783.
  • Medlinsky HL. (1974) Rickets associated with anticonvulsant medication. Pediatrics53:9195.
  • Mergler S, Evenhuis HM, Boot AM, De Man SA, Bindels-De Heus KG, Huijbers WA, Penning C. (2009) Epidemiology of low bone mineral density and fractures in children with severe cerebral palsy: a systematic review. Dev Med Child Neurol51:773778.
  • Morijiri Y, Sato T. (1981) Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. Arch Dis Child56:446449.
  • Mugica I, Ansa J, Sistiaga F, Zabalza R, Zubillaga P, Merino A, Mojedano B, Vidal C. (2002) Digital computerized absorptiometry in the diagnosis of osteoporosis in a group of the severely mentally retarded. Nutr Hosp17:213218.
  • Petty SJ, O’Brien TJ, Wark JD. (2007) Anti-epileptic medication and bone health. Osteoporos Int8:129142.
  • Roende G, Ravn K, Fuglsang K, Andersen H, Nielsen JB, Brøndum-Nielsen K, Jensen JE. (2011) DXA measurements in Rett syndrome reveal small bones with low bone mass. J Bone Miner Res26:22802286.
  • Samaniego E, Sheth RD. (2007) Bone consequences of epilepsy and antiepileptic medications. Semin Pediatr Neurol14:196200.
  • Sato Y, Kondo I, Ishida S, Motooka H, Takayama K, Tomita Y, Maeda H, Satoh K. (2001) Decreased bone mass and increased bone turnover with valproate therapy in adults with epilepsy. Neurology57:445449.
  • Schrager S. (2006) Epidemiology of osteoporosis in women with cognitive impairment. Ment Retard44:203211.
  • Shaw NJ, White CP, Fraser WD, Rosenbloom L. (1994) Osteopenia in cerebral palsy. Arch Dis Child71:235238.
  • Sheth RD. (2004) Bone health in pediatric epilepsy. Epilepsy Behav5:S30S35.
  • Sheth RD, Hermann BP. (2007) Bone mineral density with lamotrigine monotherapy for epilepsy. Pediatr Neurol37:250254.
  • Srikanth R, Cassidy G, Joiner C, Teeluckdharry S. (2011) Osteoporosis in people with intellectual disabilities: a review and a brief study of risk factors for osteoporosis in a community sample of people with intellectual disabilities. J Intellect Disabil Res55:5362.
  • Tandon N, Fall CH, Osmond C, Sachdev HP, Prabhakaran D, Ramakrishnan L, Dey Biswas SK, Ramji S, Khalil A, Geral T, Reddy KS, Barker DJ, Cooper C, Bhargawa SK. (2012) Growth from birth to adulthood and peak bone mass and density data from the New Delhi Birth Cohort. Osteoporos Int Jan 12 [Epub ahead of print].
  • Tsukahara H, Kimura K, Todoroki Y, Ohshima Y, Hiraoka M, Shigematsu Y, Tsuhkahara Y, Miura M, Mayumi M. (2002) Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy. Pediatr Int44:247253.
  • Verrotti A, Greco R, Latini G, Morgese G, Chiarelli F. (2002) Increased bone turnover in prepubertal, pubertal, and postpubertal patients receiving carbamazepine. Epilepsia43:14881492.
  • Weisman Y, Fattal A, Eisenberg Z, Harel S, Spirer Z, Harell A. (1979) Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy. Br Med J2:521523.
  • Zhang J, Wang KX, Wei Y, Xu MH, Su JM, Bao YG, Zhao SY. (2010) Effect of topiramate and carbamazepine on bone metabolism in children with epilepsy. Zhongguo Dang Dai Er Ke Za Zhi2:9698.